Valor Intrínseco del S&P y Nasdaq Contáctenos

HeartBeam, Inc. BEATW NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
44/100
2/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

HeartBeam, Inc. (BEATW) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.

Los analistas estiman Beneficio por acción (EPS) de $-0.73 y ingresos de $0.00B para el próximo año fiscal.

Historial de Beneficio por acción (EPS): 2024: real $-0.73 vs est $-0.73 (superó +0%). 2025: real $-0.62 vs est $-0.61 (no alcanzó -1.2%). Precisión del analista: 99%.

Estimaciones de BPA — BEATW

99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual –$0.73 vs Est –$0.73 ▼ 0.0% off
2025 Actual –$0.62 vs Est –$0.61 ▼ 1.2% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.

Estimaciones de Ingresos — BEATW

Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
Contáctenos
🎓
SharesGrow Academia
Aprende a calcular el Valor Intrínseco y encontrar acciones infravaloradas.
Sesiones semanales en vivo
Envíanos un mensaje